Rapid Micro Biosystems (RPID) Operating Margin (QoQ) (2020 - 2026)

Rapid Micro Biosystems (RPID) Operating Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Rapid Micro Biosystems 90.41 Mn 80.98 Mn 371,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,487.00
Dec 31, 2025 3,685.00
Sep 30, 2025 2,219.00
Jun 30, 2025 -544.00
Mar 31, 2025 -3,738.00
Dec 31, 2024 3,385.00
Sep 30, 2024 4,382.00
Jun 30, 2024 5,223.00
Mar 31, 2024 -6,204.00
Dec 31, 2023 4,280.00
Sep 30, 2023 6,583.00
Jun 30, 2023 -559.00
Mar 31, 2023 9,923.00
Dec 31, 2022 -3,828.00
Sep 30, 2022 829.00
Jun 30, 2022 -406.00
Mar 31, 2022 -8,106.00
Dec 31, 2021 -10,377.00
Sep 30, 2021 147.00
Jun 30, 2021 1,682.00